Skip to main content

Table 1 The details of dataset used in this work

From: Leveraging hybrid biomarkers in clinical endpoint prediction

Dataset characteristics No (%)
Total patients 211 100
Incomplete records 50 24
Complete records 161 76
Internal features present 68 42
 I) Air Bronchogram 24 35
 II) Cavitation 15 22
 III) Cysts 4 6
 IV) Reticulation 5 7
 V) Mix of above 20 29
Internal features absent 91 58
Gender
 Male (48/68) 71
 Female (20/68) 29
Age
  ≤ 70 (36/68) 53
  > 70 (32/68) 47
Pathological staging
Primary tumor T
 I (30/68) 44
 II (25/68) 37
 III (9/68) 13
 IV (4/68) 6
Lymph node N
 0 (56/68) 82
 1 (4/68) 6
 2 (8/68) 2
 3 0 0
Metastasis M
 0 (66/68) 97
 1 (2/68) 3
Histology
 Squamous cell (10/68) 15
 Non-Squamous cell (58/68) 85
5-year overall survival
 Survived (23/68) 34
 Expired (45/68) 66